Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review

AB Boroumand, M Forouhi, F Karimi… - Frontiers in …, 2022 - frontiersin.org
Purpose To evaluate the immunogenicity of COVID-19 vaccines in patients with diabetes
mellitus (DM) through a systematic approach. Method A comprehensive search was …

[HTML][HTML] Diabetes mellitus and COVID-19: understanding the association in light of current evidence

S Sen, R Chakraborty, P Kalita… - World journal of clinical …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have posed a
problematic healthcare situation worldwide since December 2019. Diabetes mellitus is …

Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 mRNA COVID-19 vaccination

H Ali, A Alterki, S Sindhu, B Alahmad… - Frontiers in …, 2021 - frontiersin.org
The emergence of effective vaccines for COVID-19 has been welcomed by the world with
great optimism. Given their increased susceptibility to COVID-19, the question arises …

Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: experience from Bangladesh

MA Rahman, Y Shanjana, MI Tushar, T Mahmud… - PLoS …, 2021 - journals.plos.org
Background The hematological abnormalities are assumed to be involved in the disease
progression of COVID-19. However, the actual associations between specific blood …

Epigenetic regulation of energy metabolism in obesity

W Gao, JL Liu, X Lu, Q Yang - Journal of molecular cell biology, 2021 - academic.oup.com
Obesity has reached epidemic proportions globally. Although modern adoption of a
sedentary lifestyle coupled with energy-dense nutrition is considered to be the main cause …

Nanotechnology as a shield against COVID-19: current advancement and limitations

M Rai, S Bonde, A Yadav, A Bhowmik, S Rathod… - Viruses, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a global health problem that the WHO declared a pandemic …

Insulin treatment may increase adverse outcomes in patients with COVID-19 and diabetes: a systematic review and meta-analysis

Y Yang, Z Cai, J Zhang - Frontiers in Endocrinology, 2021 - frontiersin.org
Background and Objective Recently, insulin treatment has been found to be associated with
increased mortality and other adverse outcomes in patients with coronavirus disease 2019 …

Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup

H Xu, S Sheng, W Luo, X Xu, Z Zhang - Frontiers in Immunology, 2023 - frontiersin.org
Acute respiratory distress syndrome (ARDS) is an acute diffuse inflammatory lung injury
characterized by the damage of alveolar epithelial cells and pulmonary capillary endothelial …

Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies

RE Tamura, SM Said, LM de Freitas… - Diabetology & metabolic …, 2021 - Springer
Background COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent
almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population …

National and regional trends in the prevalence of type 2 diabetes and associated risk factors among Korean adults, 2009–2021

J Oh, S Kim, M Lee, SY Rhee, MS Kim, JY Shin… - Scientific Reports, 2023 - nature.com
Disproportionate impact of COVID-19 on socioeconomic and behavioral variables may have
impacted the prevalence of diabetes. We utilized nationwide long-term serial study from the …